Skip to main content
Tharimmune, Inc. logo

Tharimmune, Inc. — Investor Relations & Filings

Ticker · THAR ISIN · US4327051011 LEI · 52990040X8C60JYNXZ70 US Manufacturing
Open in API
Filings indexed 286 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country US United States of America
Listing US THAR

About Tharimmune, Inc.

https://tharimmune.com/

Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for immunology, inflammation, and oncology. The company's pipeline includes TH104, a product candidate for treating pruritus in primary biliary cholangitis (PBC), and treatments for solid tumors that target mechanisms such as ferroptosis. In addition to its biotechnology research and development, the company is also involved in activities supporting institutional blockchain adoption and the digitization of financial markets through the Canton Network.

Recent filings

Filing Released Lang Actions
10-Q - Canton Strategic Holdings, Inc. (0001861657) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-13 English
10-K - Canton Strategic Holdings, Inc. (0001861657) (Filer)
Annual Report FY 2025
2026-03-31 English
8-K - Canton Strategic Holdings, Inc. (0001861657) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions that the company issued a press release announcing full year results for the fiscal year ended December 31, 2025, and that the press release is attached as an exhibit. The document itself does not contain the full financial statements or detailed financial data but rather references the press release. The length of the document is 3577 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and states that a report or press release is attached or available, it should be classified as a Regulatory Filing (RNS) rather than the report itself (such as an Earnings Release or Annual Report). Therefore, this document is best classified as a Regulatory Filing (RNS).
2026-03-31 English
8-K - THARIMMUNE, INC. (0001861657) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Canton Strategic Holdings, Inc. It reports a material definitive agreement related to an amended and restated sales agreement for the sale of common stock. The document includes details about the sales agreement, parties involved, and exhibits such as the sales agreement and legal opinion. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The filing is an update on a capital raising arrangement (at-the-market offering) and related agreements. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 6949 characters, which is sufficient for a substantive filing rather than a brief announcement. Hence, the classification is CAP with high confidence.
2026-03-03 English
8-K - THARIMMUNE, INC. (0001861657) (Filer)
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text specifically mentions the election of a new board member, Mark Wendland, to the Board of Directors of the Canton Foundation. There is no detailed financial data, earnings information, or comprehensive report content. The document is short (3604 characters) and includes a press release as an exhibit. This fits the category of Board/Management Information (MANG), as it announces a change in the company's board of directors. It is not an Annual Report, Earnings Release, or any other detailed financial report. Therefore, the correct classification is MANG with high confidence.
2026-03-03 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content includes a corporate name change, amendment of bylaws, and a change in trading symbol. It also references exhibits such as the amended certificate of incorporation and bylaws, and a press release. There are no financial statements or detailed financial data presented. The document is a regulatory announcement of corporate changes rather than a full report or financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2026-02-18 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.